share_log
Moomoo 24/7 ·  Apr 23 08:06
Edgewise Therapeutics Inc - EMA Orphan Drug Designations for Sevasemten (Edg-5506) for Treatment of Becker and Duchenne Muscular Dystrophies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment